Aasebø Elise, Hernandez-Valladares Maria, Selheim Frode, Berven Frode S, Brenner Annette K, Bruserud Øystein
Department of Clinical Science, Section for Hematology, University of Bergen, 5021 Bergen, Norway.
Department of Biomedicine, The Proteomics Unit at the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway.
Proteomes. 2018 Dec 20;7(1):1. doi: 10.3390/proteomes7010001.
Acute myeloid leukemia (AML) is a heterogeneous disease, and communication between leukemic cells and their neighboring leukemia-supporting normal cells is involved in leukemogenesis. The bone marrow cytokine network is therefore important, and the mediator release profile seems more important than single mediators. It is not known whether the characterization of primary AML cell proteomes reflects the heterogeneity of the broad and dynamic constitutive mediator release profile by these cells. To address this, we compared the intracellular levels of 41 proteins in 19 AML patients with the constitutive extracellular release during in vitro culture, including chemokines, growth factors, proteases, and protease regulators. The constitutive release of most mediators showed a wide variation (up to 2000-fold differences) between patients. Detectable intracellular levels were seen for 10 of 41 mediators, but for most of these 10 mediators we could not detect significant correlations between the constitutive release during in vitro culture and their intracellular levels. Intracellular protein levels in primary human AML cells do not reflect the dynamics, capacity, and variation between patients in constitutive mediator release profiles. Measurements of these profiles thus add complementary information to proteomic detection/quantification regarding the heterogeneity of the AML cell contributions to the bone marrow cytokine network.
急性髓系白血病(AML)是一种异质性疾病,白血病细胞与其邻近的支持白血病的正常细胞之间的通讯参与白血病的发生。因此,骨髓细胞因子网络很重要,介质释放谱似乎比单一介质更重要。原发性AML细胞蛋白质组的特征是否反映了这些细胞广泛而动态的组成型介质释放谱的异质性尚不清楚。为了解决这个问题,我们比较了19例AML患者体内41种蛋白质的细胞内水平与体外培养期间组成型细胞外释放情况,这些介质包括趋化因子、生长因子、蛋白酶和蛋白酶调节剂。大多数介质的组成型释放在患者之间显示出很大差异(相差高达2000倍)。41种介质中有10种可检测到细胞内水平,但对于这10种介质中的大多数,我们未能检测到体外培养期间的组成型释放与其细胞内水平之间的显著相关性。原发性人类AML细胞中的细胞内蛋白质水平并不能反映组成型介质释放谱在患者之间的动态变化、释放能力和差异。因此,这些谱的测量为蛋白质组检测/定量提供了关于AML细胞对骨髓细胞因子网络贡献异质性的补充信息。